| Eric V A Matlock, DO | |
|
901 E 5th St, Medical Staff Office, Washington, MO 63090-3127 | |
| (636) 239-8231 | |
| (636) 239-9890 |
| Full Name | Eric V A Matlock |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 22 Years |
| Location | 901 E 5th St, Washington, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093788762 | NPI | - | NPPES |
| P00769834 | Other | MO | RAILROAD MEDICARE |
| 1093788762 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2005011343 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Washington | Washington, MO | Hospital |
| Missouri Baptist Sullivan Hospital | Sullivan, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Adult Hospitalists - Washington, Llc | 3577630540 | 24 |
News Archive
Dental experts have urged parents to stop bottle-feeding their babies because of rising rates of severe tooth decay in infants as young as 12 months. In the warning from Children's Hospital at Westmead, Sydney, experts say that prolonged feeding with bottles of breast milk and infant formula are linked to the problem, especially at night, when children suck on bottles in their cots for extended periods.
Researchers from Mount Sinai and IBM have discovered a novel clue in explaining how cancer cells with identical genomes can respond differently to the same therapy.
HIV infections are treated with antiviral drugs which effectively prevent the disease from developing. While pharmacological HIV therapy has advanced considerably, the virus cannot be entirely eliminated from the body with currently available drugs.
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
During a three-year period in seven metropolitan areas in the western United States, the emergency medical services system sent more than 85,000 injured patients to major trauma hospitals who didn't need to go there - costing the health care system more than $130 million per year, according to an Oregon Health & Science University study published today in the journal Health Affairs.
› Verified 7 days ago
| Entity Name | Mercy Clinic Adult Hospitalists - St. Louis, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841235108 PECOS PAC ID: 6002809944 Enrollment ID: O20040406001004 |
News Archive
Dental experts have urged parents to stop bottle-feeding their babies because of rising rates of severe tooth decay in infants as young as 12 months. In the warning from Children's Hospital at Westmead, Sydney, experts say that prolonged feeding with bottles of breast milk and infant formula are linked to the problem, especially at night, when children suck on bottles in their cots for extended periods.
Researchers from Mount Sinai and IBM have discovered a novel clue in explaining how cancer cells with identical genomes can respond differently to the same therapy.
HIV infections are treated with antiviral drugs which effectively prevent the disease from developing. While pharmacological HIV therapy has advanced considerably, the virus cannot be entirely eliminated from the body with currently available drugs.
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
During a three-year period in seven metropolitan areas in the western United States, the emergency medical services system sent more than 85,000 injured patients to major trauma hospitals who didn't need to go there - costing the health care system more than $130 million per year, according to an Oregon Health & Science University study published today in the journal Health Affairs.
› Verified 7 days ago
| Entity Name | Mercy Clinic Adult Hospitalists - Washington, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891943429 PECOS PAC ID: 3577630540 Enrollment ID: O20080917000782 |
News Archive
Dental experts have urged parents to stop bottle-feeding their babies because of rising rates of severe tooth decay in infants as young as 12 months. In the warning from Children's Hospital at Westmead, Sydney, experts say that prolonged feeding with bottles of breast milk and infant formula are linked to the problem, especially at night, when children suck on bottles in their cots for extended periods.
Researchers from Mount Sinai and IBM have discovered a novel clue in explaining how cancer cells with identical genomes can respond differently to the same therapy.
HIV infections are treated with antiviral drugs which effectively prevent the disease from developing. While pharmacological HIV therapy has advanced considerably, the virus cannot be entirely eliminated from the body with currently available drugs.
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
During a three-year period in seven metropolitan areas in the western United States, the emergency medical services system sent more than 85,000 injured patients to major trauma hospitals who didn't need to go there - costing the health care system more than $130 million per year, according to an Oregon Health & Science University study published today in the journal Health Affairs.
› Verified 7 days ago
| Entity Name | St Anthonys Physician Organization Hospitalist Services Lc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407216336 PECOS PAC ID: 5092980656 Enrollment ID: O20111208000771 |
News Archive
Dental experts have urged parents to stop bottle-feeding their babies because of rising rates of severe tooth decay in infants as young as 12 months. In the warning from Children's Hospital at Westmead, Sydney, experts say that prolonged feeding with bottles of breast milk and infant formula are linked to the problem, especially at night, when children suck on bottles in their cots for extended periods.
Researchers from Mount Sinai and IBM have discovered a novel clue in explaining how cancer cells with identical genomes can respond differently to the same therapy.
HIV infections are treated with antiviral drugs which effectively prevent the disease from developing. While pharmacological HIV therapy has advanced considerably, the virus cannot be entirely eliminated from the body with currently available drugs.
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
During a three-year period in seven metropolitan areas in the western United States, the emergency medical services system sent more than 85,000 injured patients to major trauma hospitals who didn't need to go there - costing the health care system more than $130 million per year, according to an Oregon Health & Science University study published today in the journal Health Affairs.
› Verified 7 days ago
| Entity Name | Mercy Clinic Adult Hospitalists Jefferson Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083052492 PECOS PAC ID: 8628205598 Enrollment ID: O20131220001798 |
News Archive
Dental experts have urged parents to stop bottle-feeding their babies because of rising rates of severe tooth decay in infants as young as 12 months. In the warning from Children's Hospital at Westmead, Sydney, experts say that prolonged feeding with bottles of breast milk and infant formula are linked to the problem, especially at night, when children suck on bottles in their cots for extended periods.
Researchers from Mount Sinai and IBM have discovered a novel clue in explaining how cancer cells with identical genomes can respond differently to the same therapy.
HIV infections are treated with antiviral drugs which effectively prevent the disease from developing. While pharmacological HIV therapy has advanced considerably, the virus cannot be entirely eliminated from the body with currently available drugs.
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
During a three-year period in seven metropolitan areas in the western United States, the emergency medical services system sent more than 85,000 injured patients to major trauma hospitals who didn't need to go there - costing the health care system more than $130 million per year, according to an Oregon Health & Science University study published today in the journal Health Affairs.
› Verified 7 days ago
| Entity Name | Mercy Hospital Lincoln |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962808733 PECOS PAC ID: 5193040020 Enrollment ID: O20150623002541 |
News Archive
Dental experts have urged parents to stop bottle-feeding their babies because of rising rates of severe tooth decay in infants as young as 12 months. In the warning from Children's Hospital at Westmead, Sydney, experts say that prolonged feeding with bottles of breast milk and infant formula are linked to the problem, especially at night, when children suck on bottles in their cots for extended periods.
Researchers from Mount Sinai and IBM have discovered a novel clue in explaining how cancer cells with identical genomes can respond differently to the same therapy.
HIV infections are treated with antiviral drugs which effectively prevent the disease from developing. While pharmacological HIV therapy has advanced considerably, the virus cannot be entirely eliminated from the body with currently available drugs.
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
During a three-year period in seven metropolitan areas in the western United States, the emergency medical services system sent more than 85,000 injured patients to major trauma hospitals who didn't need to go there - costing the health care system more than $130 million per year, according to an Oregon Health & Science University study published today in the journal Health Affairs.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric V A Matlock, DO Po Box 502852, Saint Louis, MO 63150-2852 Ph: (314) 364-4200 | Eric V A Matlock, DO 901 E 5th St, Medical Staff Office, Washington, MO 63090-3127 Ph: (636) 239-8231 |
News Archive
Dental experts have urged parents to stop bottle-feeding their babies because of rising rates of severe tooth decay in infants as young as 12 months. In the warning from Children's Hospital at Westmead, Sydney, experts say that prolonged feeding with bottles of breast milk and infant formula are linked to the problem, especially at night, when children suck on bottles in their cots for extended periods.
Researchers from Mount Sinai and IBM have discovered a novel clue in explaining how cancer cells with identical genomes can respond differently to the same therapy.
HIV infections are treated with antiviral drugs which effectively prevent the disease from developing. While pharmacological HIV therapy has advanced considerably, the virus cannot be entirely eliminated from the body with currently available drugs.
OncoGenex Pharmaceuticals announced today that it has received written, scientific advice from the European Medicines Agency (EMA) on the company's development plan for OGX-011 (also known as custirsen) for the treatment of men with metastatic castrate-resistant prostate cancer (mCRPC). The input received from the Committee for Medicinal Products for Human Use (CHMP) at the EMA was in overall agreement with OncoGenex's development plan regarding the proposed preclinical studies and both the study designs and analyses for the Phase III trials.
During a three-year period in seven metropolitan areas in the western United States, the emergency medical services system sent more than 85,000 injured patients to major trauma hospitals who didn't need to go there - costing the health care system more than $130 million per year, according to an Oregon Health & Science University study published today in the journal Health Affairs.
› Verified 7 days ago
Katarzyna Anne Kohler, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 Patients First Dr, Suite 1200, Washington, MO 63090 Phone: 636-390-1777 Fax: 636-390-1778 | |
Jean Kirsten Hertz, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 209 Rand St, Washington, MO 63090 Phone: 636-390-2149 Fax: 636-390-9369 | |
Dr. Rajasekhar Reddy Bhoda, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 E 5th St, Washington, MO 63090 Phone: 636-239-8231 | |
Amy L Couch, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 Patients First Dr, Suite 1200, Washington, MO 63090 Phone: 636-390-1777 | |
Mr. Todd Martin Craig, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 851 E 5th St, Suite 200, Washington, MO 63090 Phone: 636-239-8656 Fax: 636-239-8553 | |
Dr. Kim D Colter, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 Patients First Dr, Washington, MO 63090 Phone: 636-239-4100 Fax: 636-390-4341 |